Genmont Biotech Inc. - Taiwan
Figures in New Taiwan dollars.
2026 2025
Revenue NT$38,270,000 NT$43,777,000
Jan-Mar Revenue NT$89,170,000 NT$99,452,000
Source: Taiwan Stock Exchange This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.